- Home
- CING vs GDTC Comparison
CING vs GDTC Comparison
Compare CING & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- GDTC
- Stock Information
- Founded
- CING 2012
- GDTC 2018
- Country
- CING United States
- GDTC Singapore
- Employees
- CING N/A
- GDTC N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- CING Health Care
- GDTC Health Care
- Exchange
- CING Nasdaq
- GDTC Nasdaq
- Market Cap
- CING 26.7M
- GDTC 22.9M
- IPO Year
- CING 2021
- GDTC 2023
- Fundamental
- Price
- CING $3.86
- GDTC $1.95
- Analyst Decision
- CING Strong Buy
- GDTC Buy
- Analyst Count
- CING 4
- GDTC 1
- Target Price
- CING $31.00
- GDTC $5.00
- AVG Volume (30 Days)
- CING 153.1K
- GDTC 10.4K
- Earning Date
- CING 11-06-2025
- GDTC 01-01-0001
- Dividend Yield
- CING N/A
- GDTC N/A
- EPS Growth
- CING N/A
- GDTC N/A
- EPS
- CING N/A
- GDTC N/A
- Revenue
- CING N/A
- GDTC $368,838.00
- Revenue This Year
- CING N/A
- GDTC $5.37
- Revenue Next Year
- CING N/A
- GDTC N/A
- P/E Ratio
- CING N/A
- GDTC N/A
- Revenue Growth
- CING N/A
- GDTC N/A
- 52 Week Low
- CING $3.02
- GDTC $1.20
- 52 Week High
- CING $7.00
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- CING 43.49
- GDTC 52.90
- Support Level
- CING $3.61
- GDTC $1.85
- Resistance Level
- CING $4.12
- GDTC $2.07
- Average True Range (ATR)
- CING 0.25
- GDTC 0.09
- MACD
- CING 0.00
- GDTC 0.01
- Stochastic Oscillator
- CING 30.91
- GDTC 61.35
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.